Huaxin Capital
Overview
Huaxin Capital is a Shenzhen-based venture capital and private equity firm established in 2011, specializing in early and growth-stage investments across sectors including biomedicine, medical equipment, IoT, new energy, and high-end manufacturing.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| New Carzone | Jun 2015 | Series A Extension | Co-investor |
| Xiamen ZhiTong Technology Co., Ltd. | Nov 2016 | Series C | Co-investor |
| Aratek Biometrics | Aug 2012 | Series A | Co-investor |
| Shenzhen Xinhuan Technology Co., Ltd. | Dec 2025 | A+ Round | Co-investor |
| Dapu Biotechnology | Jan 2024 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Huaxin Capital based?
Huaxin Capital is headquartered in Shenzhen, China.
When was Huaxin Capital founded?
Huaxin Capital was founded in 2011.
How many portfolio companies does Huaxin Capital have?
Huaxin Capital has 6 portfolio companies in Caplight's dataset.
What are some companies in Huaxin Capital's portfolio?
Portfolio companies visible on Caplight include New Carzone, Xiamen ZhiTong Technology Co., Ltd., Aratek Biometrics, Shenzhen Xinhuan Technology Co., Ltd., Dapu Biotechnology.
What was Huaxin Capital's most recent investment shown here?
Huaxin Capital's most recent investment in this portfolio sample was in Shenzhen Xinhuan Technology Co., Ltd. in 2025.
What sectors does Huaxin Capital focus on?
Huaxin Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech, Cybersecurity, Enterprise Software, Enterprise Software, Mobility, Transportation & Logistics, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Huaxin Capital focus on?
Huaxin Capital typically invests at the Early stage.
What is Huaxin Capital's AUM?
Huaxin Capital's assets under management are estimated between $138.0M and $276.0M.